Literature DB >> 22228238

Preoperative and intraoperative prediction of risk of cardiac dysfunction following open heart surgery.

Yunita Widyastuti1, Roar Stenseth, Kristin S Berg, Hilde Pleym, Alexander Wahba, Vibeke Videm.   

Abstract

CONTEXT: Cardiac dysfunction following open heart surgery is a major determinant of subsequent morbidity and mortality.
OBJECTIVES: To develop a specific risk prediction model for postoperative cardiac dysfunction based on preoperative variables, to investigate whether prediction could be improved by inclusion of selected intraoperative variables and to compare our model with five previously published risk scores.
DESIGN: Single-centre prospectively collected data.
SETTING: Tertiary care centre, Middle Norway. PATIENTS: Four thousand nine hundred and eighty-nine patients (all eligible) undergoing open cardiac surgery from 2000 to 2007. MAIN OUTCOME MEASURES: Logistic regression models for postoperative cardiac dysfunction: predictive accuracy/calibration, discrimination as shown by area under the receiver operating characteristics curve, internal validity as indicated by bootstrapping, comparison of goodness-of-fit with predictions based on alternative risk scores.
RESULTS: The preoperative model included chronic cardiac insufficiency, previous myocardial infarction, previous cardiac operation, pulmonary hypertension, renal dysfunction, low haemoglobin concentration, urgent operation and operation type other than isolated coronary artery bypass surgery. The area under the curve was 0.838 [95% confidence interval (CI) 0.812-0.864]. Risk prediction was accurate apart from a slight overestimation in the 2% of highest risk patients. Inclusion of a few intraoperative variables (inotropic or vasoconstrictor drugs, plasma or red cell transfusion) improved the model slightly, increasing the area under the curve to 0.875 (95% CI 0.854-0.896) or 0.890 (95% CI 0.863-0.902) for two equivalent models. On the basis of estimated shrinkage factors of 0.94, 0.97 and 0.98, respectively, the models should behave with 6% or less error in future datasets. Our preoperative model was significantly better than the previously published risk scores (P < 0.0002 for comparison of area under the curves).
CONCLUSION: The preoperative model including variables obtained easily in routine clinical work performed well and was improved only slightly by inclusion of intraoperative variables. Performance was better than those of the five previously published risk scores.

Entities:  

Mesh:

Year:  2012        PMID: 22228238     DOI: 10.1097/EJA.0b013e32834de368

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  5 in total

1.  Length of intensive care unit stay following cardiac surgery: is it impossible to find a universal prediction model?

Authors:  Yunita Widyastuti; Roar Stenseth; Alexander Wahba; Hilde Pleym; Vibeke Videm
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-24

2.  Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass.

Authors:  Yumiko Yamazaki; Koji Oba; Yoshiro Matsui; Yuji Morimoto
Journal:  J Anesth       Date:  2018-01-13       Impact factor: 2.078

Review 3.  Ventriculo-arterial decoupling in acutely altered hemodynamic states.

Authors:  Fabio Guarracino; Rubia Baldassarri; Michael R Pinsky
Journal:  Crit Care       Date:  2013-03-19       Impact factor: 9.097

4.  Is Vasoactive-Inotropic Score a Predictor for Mortality and Morbidity in Patients Undergoing Coronary Artery Bypass Surgery?

Authors:  Pınar Karaca Baysal; Füsun Güzelmeriç; Ersin Kahraman; Mustafa Emre Gürcü; Atakan Erkılınç; Tülay Orki
Journal:  Braz J Cardiovasc Surg       Date:  2021-12-03

5.  Reduced Long-Term Relative Survival in Females and Younger Adults Undergoing Cardiac Surgery: A Prospective Cohort Study.

Authors:  Tone Bull Enger; Hilde Pleym; Roar Stenseth; Guri Greiff; Alexander Wahba; Vibeke Videm
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.